BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
BRCA1
,
cell-cell adhesion
,
Ischemia
,
Prostate
,
Pharmacogenetics
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PAK4
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Superior cervical ganglion
Skeletal muscle psoas
Atrioventricular node
Appendix
Testis seminiferous tubule
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Middle East respiratory syndrome
Ulceration of intestine
Irritable bowel syndrome
Injury of lung
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Dimethylnitrosamine
Diphenhydramine
Ritonavir
Sulfamethizole
Cefamandole
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR142
BCL10
NIPSNAP1
FHL2
ACVR1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
p21-activated kinase 4 counteracts PKA-dependent lipolysis by phosphorylating FABP4 and HSL.
PAK4 phosphorylates and inhibits AMPKα to control glucose uptake.
Interaction between p21-activated kinase 4 and β-catenin as a novel pathway for PTH-dependent osteob…
PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltra…
p21-activated kinase 4 suppresses fatty acid β-oxidation and ketogenesis by phosphorylating NCoR1.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgk…
PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)
KPT-9274 in Patients With Relapsed and Refractory Acute Myeloid Leukemia
This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Ad…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ